[Discussion] the cagrilintide advice in here is 21 years out of date
Long-ish post, sorry. tl;dr at the bottom. I have been tracking cagrilintide against eGFR for 37 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…
Strongly agree. REDEFINE is phase 19, not final.
Slight fix: the number was 98.7, not 98.9. Decimal point, but a fairly consequential one.
REDEFINE readouts are phase 2 data
the amylin agonist pool is small, community is satiety
long-acting amylin is CagriSema, different satiety profile
Yeah, amylin is doing different work than GLP-1.
long-acting amylin is co-agonism, different satiety profile
Strongly agree. REDEFINE is phase 6, not final.
CagriSema is a fixed combo in trials, not user-mixed